9 results
Brief Overview of Treatment Agents for COVID-19 - Version 2.01 4/11/2020

#Drugs #Medications #Treatment #COVID19 #Pharmacology #Table
Brief Overview of ... Treatment Agents for COVID ... Medications #Treatment #COVID19 ... #Pharmacology # ... Table #Management
Running out of Analgesia and Sedation Medications due to #COVID19?  Anand Swaminathan, MD has put
Medications due to #COVID19 ... options in REBEL Review ... #management #covid19 ... treatment #sarscov2 #criticalcare ... sedative #analgesia #pharmacology
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
virus causing COVID ... here is a quick overview ... ivermectin… #COVID19 ... InfectiousDiseases #CriticalCare ... EmergencyMedicine #Pharmacology
Statins intensity, drug interactions, timing of administration and missed doses.

An overview of high, moderate and low
An overview of high ... #pharmacology #overview ... #review #dosing ... comparison #drugs #table
REBEL Review 4 & 5: Paralytic & Vasopressor Dosing 

Paralytic Agents:
 - Succinylcholine (Depolarizing Agent)
REBEL Review 4 & ... resuscitation #table ... #criticalcare # ... pharmacology #dosing
COVID-19 review…here is a list of some of the drugs that are currently being used or
COVID-19 review… ... investigated for COVID ... treatments for COVID ... Pharmacotherapy #Pharmacology ... #CriticalCare #
ANTIBIOTIC SUSCEPTIBILITIES IN INTENSIVE CARE

Antibiotic spectra made simple(r). Version 2, now updated with new bugs &
Susceptibilities #ICU #CriticalCare ... #Overview #Pharmacology ... Comprehensive Review
Daptomycin  - Antibiotics Class Overview

Mechanism: Lipopeptide antibiotic – forms transmembrane channels and depolarizes cells.
Antibiotics Class Overview ... and depolarizes cells ... cidal nature) #Pharmacology ... #Antibiotics #Review ... #Overview #Daptomycin
Tenofovir is one of the most commonly used NRTI's! The original formulation is tenofovir disoproxil fumarate
until the lymphoid cells ... Additionally TAF is able ... produced in a smaller tablet ... has been under review ... #alafenamide #Pharmacology